Please login to the form below

Not currently logged in
Email:
Password:

medicines

This page shows the latest medicines news and features for those working in and with pharma, biotech and healthcare.

With Spiriva under pressure, Boehringer moves to bolster pipeline

With Spiriva under pressure, Boehringer moves to bolster pipeline

The delivery technology is designed to reduce systemic absorption, allowing medicines to be taken directly from the gastrointestinal tract into the blood vessels that serve the lymphatic system and from there

Latest news

More from news
Approximately 143 fully matching, plus 3,622 partially matching documents found.

Latest Intelligence

  • From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality

    How pharma is progressing their commitment in patient engagement. In 2014, the European Medicines Agency (EMA) gave the first indication that layperson summaries of the results of pharma-sponsored clinical trials

  • The first, my last, my everything The first, my last, my everything

    This growing empowerment arguably has its biggest impact in the arena of high-value medicines. ... The patient voice is increasingly being used to influence payers and encourage them to support high-value medicines.

  • Vertex: a vision of treating all CF patients worldwide draws closer Vertex: a vision of treating all CF patients worldwide draws closer

    Speaking about its gamble on CF, CEO Jeff Leiden said: “When we started in CF and said we were going to make a medicine that could actually fix this misfolded, mutated ... Jeff Leiden, Vertex CEO. The company built on its initial ‘precision

  • The Orkambi row explained The Orkambi row explained

    The Orkambi timeline. July 2012: Vertex’s Kalydeco, the first medicine to treat the underlying cause of cystic fibrosis, is approved in Europe. ... March 2019: Vertex, NHSE and NICE meet with Matt Hancock to recommence discussions on cystic fibrosis

  • The Orkambi blame game The Orkambi blame game

    We really cannot do so and fulfil our promise to patients around the world that we will find them all the medicines for their diseases.”. ... is to capture the full value of specialist medicines for small populations.

More from intelligence
Approximately 20 fully matching, plus 465 partially matching documents found.

Latest appointments

More from appointments
Approximately 10 fully matching, plus 341 partially matching documents found.

Latest from PMHub

  • emotive supports Rare Disease Day 2019

    On 20th  February, we attended ‘The Unusual Suspects: Rare Diseases in Everyday Medical Care” at the Royal Society of Medicine, hosted by Medics 4 Rare Diseases (M4RD).  . ... work we do in such an innovative area of medicine.   .

  • Adding different perspectives to scientific communications at Porterhouse Medical

    Lauren graduated from the University of Cambridge, School of Clinical Medicine and worked in clinical practice for five years. ... This career change will enable Lauren to combine her interests in medicine, writing and medical education, while her

  • Mednet Group’s growth spurt

    ve settled in quickly with the team being so friendly and I’m looking forward to getting involved in a range of projects in the field of healthcare and medicine.”.

  • New opportunities in emerging markets

    This growth is set to continue. In parallel, we are seeing an increased focus among emerging market governments on public healthcare reform: expanding their populations’ access to medicines by establishing universal ... Greater purchasing power and

  • The 7 biggest risks to e-detailing success

    E-detailers promote medicines to healthcare professionals (HCPs) over the phone and via online platforms, such as WebEx.

More from PMHub
Approximately 18 fully matching, plus 264 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics